Reduced Graphene Oxide‐GelMA Hybrid Hydrogels as Scaffolds for Cardiac Tissue Engineering. Issue 27 (2nd June 2016)

• Record Type: Journal Article
• Authors: Shin, Su Ryon; Zihlmann, Claudio; Akbari, Mohsen; Assawes, Pribpandao; Cheung, Louis; Zhang, Kaizhen; Manoharan, Vijayan; Zhang, Yu Shrike; Yüksekkaya, Mehmet; Wan, Kai‐tak; Nikkhah, Mehdi; Dokmeci, Mehmet R.; Tang, Xiaowu (Shirley); Khademhosseini, Ali
• Is Part Of: Small. Volume 12:Issue 27(2016)
• Page Start: 3677
• Page End: 3689
• Publication Date: 2016-06-02
• Subjects: bioactuator -- cardiac tissue engineering -- gelatin -- hydrogel -- reduced graphene oxide; Nanotechnology -- Periodicals; Nanoparticles -- Periodicals; Microtechnology -- Periodicals; 620.5
• DOI: 10.1002/smll.201600178
• Languages: English
• ISSNs: 1613-6810

Abstract

Abstract : Biomaterials currently used in cardiac tissue engineering have certain limitations, such as lack of electrical conductivity and appropriate mechanical properties, which are two parameters playing a key role in regulating cardiac cell behavior. Here, the myocardial tissue constructs are engineered based on reduced graphene oxide (rGO)‐incorporated gelatin methacryloyl (GelMA) hybrid hydrogels. The incorporation of rGO into the GelMA matrix significantly enhances the electrical conductivity and mechanical properties of the material. Moreover, cells cultured on composite rGO‐GelMA scaffolds exhibit better biological activities such as cell viability, proliferation, and maturation compared to ones cultured on GelMA hydrogels. Cardiomyocytes show stronger contractility and faster spontaneous beating rate on rGO‐GelMA hydrogel sheets compared to those on pristine GelMA hydrogels, as well as GO‐GelMA hydrogel sheets with similar mechanical property and particle concentration. Our strategy of integrating rGO within a biocompatible hydrogel is expected to be broadly applicable for future biomaterial designs to improve tissue engineering outcomes. The engineered cardiac tissue constructs using rGO incorporated hybrid hydrogels can potentially provide high‐fidelity tissue models for drug studies and the investigations of cardiac tissue development and/or disease processes in vitro. Abstract : Incorporating reduced graphene oxide (rGO) inside GelMA hydrogels enhanced their electrical conductivity and mechanical properties. Cardiomyocytes showed faster spontaneous beating rate and higher expression of cardiac markers on rGO‐GelMA hydrogels compared to those on pristine GelMA and GO‐GelMA hydrogel. rGO reinforcement combined with an extracellular matrix‐derived biopolymer offers a promising material for fabrication of tissue constructs for cardiac tissue engineering.